Cancer study tracks 2,000+ patients to predict dangerous treatment side effects

NCT ID NCT04871542

Recruiting now Knowledge-focused Sponsor: SWOG Cancer Research Network Source: ClinicalTrials.gov ↗

Summary

This study aims to understand why some cancer patients develop serious side effects from immunotherapy drugs while others don't. Researchers will follow 2,062 patients with solid tumors who are starting standard immunotherapy treatment. By tracking side effects, collecting blood samples, and having patients complete regular questionnaires, they hope to identify risk factors that could help doctors predict and prevent severe reactions in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Mary Greeley Medical Center
RECRUITING

Ames, Iowa, 50010, United States

Contact

Contact Phone: •••-•••-••••
McFarland Clinic PC - Ames
RECRUITING

Ames, Iowa, 50010, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
McFarland Clinic PC-Boone
RECRUITING

Boone, Iowa, 50036, United States

Contact

Contact Phone: •••-•••-••••
McFarland Clinic PC-Jefferson
RECRUITING

Jefferson, Iowa, 50129, United States

Contact

Contact Phone: •••-•••-••••
McFarland Clinic PC-Marshalltown
RECRUITING

Marshalltown, Iowa, 50158, United States

Contact

Contact Phone: •••-•••-••••
McFarland Clinic PC-Trinity Cancer Center
RECRUITING

Fort Dodge, Iowa, 50501, United States

Contact

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

MALIGNANT SOLID NEOPLASM